Oppenheimer & Co’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,687
Closed -$73K 1507
2020
Q4
$73K Buy
4,687
+629
+16% +$9.8K ﹤0.01% 1320
2020
Q3
$39K Sell
4,058
-75
-2% -$721 ﹤0.01% 1267
2020
Q2
$93K Hold
4,133
﹤0.01% 1209
2020
Q1
$75K Buy
4,133
+2,582
+166% +$46.9K ﹤0.01% 1137
2019
Q4
$182K Buy
1,551
+402
+35% +$47.2K ﹤0.01% 1196
2019
Q3
$104K Buy
+1,149
New +$104K ﹤0.01% 1212